Showing results (11-20 of 78) with videos related to
Sort By:
Pageof 8
Annals of Hematology|November 16, 2018
Copanlisib, a novel phosphoinositide 3-kinase inhibitor, combined with carfilzomib inhibits multiple myeloma cell proliferationSeiichi Okabe, Yuko Tanaka, Tetsuzo Tauchi, et al.Journal of Hematology & Oncology|August 3, 2011
Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell lineSeiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, et al.Oncotarget|September 11, 2018
Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cellsSeiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, et al.Biochemical and Biophysical Research Communications|May 21, 2013
Efficacy of ponatinib against ABL tyrosine kinase inhibitor-resistant leukemia cellsSeiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, et al.Blood Cells, Molecules & Diseases|March 1, 2006
Stromal-cell-derived factor-1/CXCL12-induced chemotaxis of a T cell line involves intracellular signaling through Cbl and Cbl-b and their regulation by Src kinases and CD45Seiichi Okabe, Tetsuzo Tauchi, Kazuma Ohyashiki, et al.Oncogene|February 19, 2002
Telomeres and telomerase in hematologic neoplasiaJunko H Ohyashiki, Goro Sashida, Tetsuzo Tauchi, et al.Biochemical and Biophysical Research Communications|April 3, 2009
Mechanism of MK-0457 efficacy against BCR-ABL positive leukemia cellsSeiichi Okabe, Tetsuzo Tauchi, Junko H Ohyashiki, et al.Journal of Biochemistry, Molecular Biology, and Biophysics : JBMBB : the Official Journal of the Federation of Asian and Oceanian Biochemists and Molecular Biologists (FAOBMB)|August 21, 2002
Enriched levels of erythropoietin in human umbilical cord blood stimulate hematopoietic progenitor cellsGeorge F Lawlor, Tetsuzo Tauchi, Kazuma Ohyashiki, et al.Journal of Hematology & Oncology|April 30, 2014
Combination of the ABL kinase inhibitor imatinib with the Janus kinase 2 inhibitor TG101348 for targeting residual BCR-ABL-positive cellsSeiichi Okabe, Tetsuzo Tauchi, Seiichiro Katagiri, et al.Journal of Hematology & Oncology|August 5, 2015
Anti-leukemic activity of axitinib against cells harboring the BCR-ABL T315I point mutationSeiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, et al.Pageof 8